Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy.
Romaniello D, Gelfo V, Pagano F, Sgarzi M, Morselli A, Girone C, Filippini DM, D'Uva G, Lauriola M. Romaniello D, et al. Among authors: morselli a. Front Cell Dev Biol. 2023 Jan 12;10:1083743. doi: 10.3389/fcell.2022.1083743. eCollection 2022. Front Cell Dev Biol. 2023. PMID: 36712972 Free PMC article. Review.
Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation.
Sgarzi M, Mazzeschi M, Santi S, Montacci E, Panciera T, Ferlizza E, Girone C, Morselli A, Gelfo V, Kuhre RS, Cavallo C, Valente S, Pasquinelli G, Győrffy B, D'Uva G, Romaniello D, Lauriola M. Sgarzi M, et al. Among authors: morselli a. Commun Biol. 2023 Oct 14;6(1):1044. doi: 10.1038/s42003-023-05411-y. Commun Biol. 2023. PMID: 37838732 Free PMC article.
Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies.
Miano C, Romaniello D, Mazzeschi M, Morselli A, Da Pra S, Sacchi F, Bongiovanni C, Sgarzi M, Pantano E, Lauriola M, D'Uva G. Miano C, et al. Among authors: morselli a. Front Oncol. 2022 May 18;12:831105. doi: 10.3389/fonc.2022.831105. eCollection 2022. Front Oncol. 2022. PMID: 35664762 Free PMC article.
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer.
Mazzeschi M, Sgarzi M, Romaniello D, Gelfo V, Cavallo C, Ambrosi F, Morselli A, Miano C, Laprovitera N, Girone C, Ferracin M, Santi S, Rihawi K, Ardizzoni A, Fiorentino M, D'Uva G, Győrffy B, Palmer R, Lauriola M. Mazzeschi M, et al. Among authors: morselli a. J Exp Clin Cancer Res. 2022 Mar 29;41(1):113. doi: 10.1186/s13046-022-02309-1. J Exp Clin Cancer Res. 2022. PMID: 35351152 Free PMC article.